113 related articles for article (PubMed ID: 9199273)
1. Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis.
O'Kane MJ; Lynch PL; Callender ME; Trimble ER
Atherosclerosis; 1997 Jun; 131(2):203-10. PubMed ID: 9199273
[TBL] [Abstract][Full Text] [Related]
2. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
3. Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis.
Gregory WL; Game FL; Farrer M; Idle JR; Laker MF; James OF
Atherosclerosis; 1994 Jan; 105(1):43-50. PubMed ID: 8155087
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of plasma lipoprotein components assessed by ultracentrifugation in primary biliary cirrhosis and chronic hepatitis.
Tacikowski T; Milewski B; Dzieniszewski J; Nowicka G; Walewska-Zielecka B
Med Sci Monit; 2000; 6(2):325-9. PubMed ID: 11208331
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
6. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction.
Luc G; Majd Z; Poulain P; Elkhalil L; Fruchart JC
Atherosclerosis; 1996 Nov; 127(1):131-7. PubMed ID: 9006813
[TBL] [Abstract][Full Text] [Related]
7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein and lipid abnormalities in chronic liver failure.
Spósito AC; Vinagre CG; Pandullo FL; Mies S; Raia S; Ramires JA
Braz J Med Biol Res; 1997 Nov; 30(11):1287-90. PubMed ID: 9532235
[TBL] [Abstract][Full Text] [Related]
9. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
10. Observed relationship between ratios HDL-cholesterol/total cholesterol and apolipoprotein A1/apolipoprotein B.
Kuyl JM; Mendelsohn D
Clin Biochem; 1992 Oct; 25(5):313-6. PubMed ID: 1490290
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
12. Apolipoproteins A1 and B levels and serum cholinesterase activity in hyperlipidemic subjects.
Olinic D; Stoia M; Marian I; Trif I; Cucuianu M
Rom J Intern Med; 1999; 37(1):71-9. PubMed ID: 15523947
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics.
Gylling H; Färkkilä M; Vuoristo M; Miettinen TA
Hepatology; 1995 Jan; 21(1):89-95. PubMed ID: 7806174
[TBL] [Abstract][Full Text] [Related]
14. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
[TBL] [Abstract][Full Text] [Related]
15. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population.
Yang MH; Sung J; Gwak GY
J Clin Lipidol; 2016; 10(2):289-98. PubMed ID: 27055959
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
17. Abnormal high density lipoprotein of primary biliary cirrhosis analyzed by high performance liquid chromatography.
Teramoto T; Kato H; Hashimoto Y; Kinoshita M; Toda G; Oka H
Clin Chim Acta; 1985 Jul; 149(2-3):135-48. PubMed ID: 3928205
[TBL] [Abstract][Full Text] [Related]
18. [Lipids and apoproteins A1 and B in patients with ischemic heart disease with stenosing atherosclerosis of the coronary arteries and the abdominal aorta].
Kurdanov KhA; Perova NV; Polesskiĭ VA; Agapov AA; Metel'skaia VA
Kardiologiia; 1984 Oct; 24(10):84-7. PubMed ID: 6441061
[TBL] [Abstract][Full Text] [Related]
19. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.
Yamamoto A; Horibe H; Mabuchi H; Kita T; Matsuzawa Y; Saito Y; Nakaya N; Fujioka T; Tenba H; Kawaguchi A; Nakamura H; Goto Y
Atherosclerosis; 1999 Mar; 143(1):55-73. PubMed ID: 10208480
[TBL] [Abstract][Full Text] [Related]
20. Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a).
Vallance DT; Byrne DJ; Winder AF
Clin Chim Acta; 1994 Sep; 229(1-2):77-85. PubMed ID: 7988057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
